Sarah M Szymkowicz1, Vonetta M Dotson1, Jacob D Jones2, Michael S Okun3, Dawn Bowers1. 1. 1Department of Clinical & Health Psychology,College of Public Health & Health Professions,University of Florida,Gainesville,Florida. 2. 3Department of Psychiatry & Biobehavioral Sciences,David Geffen School of Medicine,University of California - Los Angeles,Los Angeles,California. 3. 4Department of Neurology,College of Medicine,University of Florida,Gainesville,Florida.
Abstract
OBJECTIVES: Both depression and apathy, alone and in combination, have been shown to negatively affect cognition in patients with Parkinson's disease (PD). However, the influence of specific symptom dimensions of depression and apathy on cognition is not well understood. The current study investigated the relationship between symptom dimensions of depression and apathy, based on factors identified in Kirsch-Darrow et al. (2011), and memory and executive function in PD. METHODS: A sample of 138 non-demented individuals with PD (mean age=64.51±7.43 years) underwent neuropsychological testing and completed the Beck Depression Inventory, 2nd Edition, and Apathy Scale. Separate hierarchical regression models examined the relationship between symptom dimensions of depression and apathy ("pure" depressive symptoms, "pure" apathy, loss of interest/pleasure [anhedonia], and somatic symptoms) and three cognitive domain composites: immediate verbal memory, delayed verbal memory, and executive function. RESULTS: After adjusting for general cognitive status and the influence of the other symptom dimensions, "pure" depressive symptoms were negatively associated with the delayed verbal memory composite (p<.034) and somatic symptoms were positively associated with the executive function composite (p<.026). No symptom dimensions were significantly related to the immediate verbal memory composite. CONCLUSIONS: Findings suggest that specific mood symptoms are associated with delayed verbal memory and executive function performance in non-demented patients with PD. Further research is needed to better understand possible mechanisms through which specific symptom dimensions of depression and apathy are associated with cognition in PD. (JINS, 2018, 24, 269-282).
OBJECTIVES: Both depression and apathy, alone and in combination, have been shown to negatively affect cognition in patients with Parkinson's disease (PD). However, the influence of specific symptom dimensions of depression and apathy on cognition is not well understood. The current study investigated the relationship between symptom dimensions of depression and apathy, based on factors identified in Kirsch-Darrow et al. (2011), and memory and executive function in PD. METHODS: A sample of 138 non-demented individuals with PD (mean age=64.51±7.43 years) underwent neuropsychological testing and completed the Beck Depression Inventory, 2nd Edition, and Apathy Scale. Separate hierarchical regression models examined the relationship between symptom dimensions of depression and apathy ("pure" depressive symptoms, "pure" apathy, loss of interest/pleasure [anhedonia], and somatic symptoms) and three cognitive domain composites: immediate verbal memory, delayed verbal memory, and executive function. RESULTS: After adjusting for general cognitive status and the influence of the other symptom dimensions, "pure" depressive symptoms were negatively associated with the delayed verbal memory composite (p<.034) and somatic symptoms were positively associated with the executive function composite (p<.026). No symptom dimensions were significantly related to the immediate verbal memory composite. CONCLUSIONS: Findings suggest that specific mood symptoms are associated with delayed verbal memory and executive function performance in non-demented patients with PD. Further research is needed to better understand possible mechanisms through which specific symptom dimensions of depression and apathy are associated with cognition in PD. (JINS, 2018, 24, 269-282).
Entities:
Keywords:
Emotion; Executive function; Memory; Mood; Movement disorders; Neuropsychology
Authors: Christopher G Goetz; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Carl Counsell; Nir Giladi; Robert G Holloway; Charity G Moore; Gregor K Wenning; Melvin D Yahr; Lisa Seidl Journal: Mov Disord Date: 2004-09 Impact factor: 10.338
Authors: Molly E McLaren; Sarah M Szymkowicz; Andrew O'Shea; Adam J Woods; Stephen D Anton; Vonetta M Dotson Journal: Psychiatry Res Neuroimaging Date: 2016-12-16 Impact factor: 2.376
Authors: Paul S Foster; Valeria Drago; Kelli Mendez; John C Witt; Gregory P Crucian; Kenneth M Heilman Journal: J Clin Exp Neuropsychol Date: 2013-01-16 Impact factor: 2.475
Authors: Jacob D Jones; Natalie E Kurniadi; Taylor P Kuhn; Sarah M Szymkowicz; Joseph Bunch; Elizabeth Rahmani Journal: Neuropsychology Date: 2019-07-25 Impact factor: 3.295
Authors: Sarah M Szymkowicz; Jacob D Jones; Holly Timblin; Cameron A Ryczek; Warren D Taylor; Pamela E May Journal: Am J Geriatr Psychiatry Date: 2021-11-21 Impact factor: 7.996
Authors: John B Wetmore; José Matías Arbelo; María José Catalán; Francesc Valldeoriola; Carmen Rodriguez-Blazquez; Pablo Martinez-Martin Journal: Parkinsons Dis Date: 2019-03-28